-
- News
- Books
Featured Books
- smt007 Magazine
Latest Issues
Current IssueComing to Terms With AI
In this issue, we examine the profound effect artificial intelligence and machine learning are having on manufacturing and business processes. We follow technology, innovation, and money as automation becomes the new key indicator of growth in our industry.
Box Build
One trend is to add box build and final assembly to your product offering. In this issue, we explore the opportunities and risks of adding system assembly to your service portfolio.
IPC APEX EXPO 2024 Pre-show
This month’s issue devotes its pages to a comprehensive preview of the IPC APEX EXPO 2024 event. Whether your role is technical or business, if you're new-to-the-industry or seasoned veteran, you'll find value throughout this program.
- Articles
- Columns
Search Console
- Links
- Events
||| MENU - smt007 Magazine
ISSYS Awarded $1.97 Million For Development of MEMS-based Multi-Drug Infusion Systems
October 21, 2003 |Estimated reading time: 1 minute
Ypsilanti, Mich. — Integrated Sensing Systems Inc (ISSYS) has been awarded $1.97 million from the National Institute of Standards and Technology's Advanced Technology Program (NIST-ATP).
The award, "Multi-Drug, Portable Infusion System for the Treatment of Cancer & AIDS" is dedicated to developing a portable and highly accurate multi-drug infusion system that integrates the technology of microelectromechanical systems (MEMS) with a passively pressurized drug reservoir, thereby dramatically improving control of drug delivery and keeping power requirements low. The system reportedly will simultaneously or sequentially deliver up to 12 drugs in units of nano-liters to micro-liters and allow improved medication therapies to be implemented by reprogramming the delivery controls. While many diseases require multiple drugs to be administered with high accuracy, two specific diseases are selected as testbeds: cancer and AIDS. Cancer is treated with multi-drug chemotherapy and AIDS is treated with drug "cocktails." The need for multi-drug infusion has been met inadequately by existing infusion pumps because of shortcomings in their size, weight, accuracy, and power consumption. ISSYS' technology reportedly represents a major paradigm shift and has the potential to revolutionize the low-flow delivery field by offering an unprecedented accuracy for low flow measurement in a small size and requiring very low power. ISSYS' core technology, for the first time, makes it possible to reliably produce intelligent, dynamic, programmable, low-volume, multi-fluid delivery systems at a reasonable cost. This system also measures the density of the drug, which will be used to detect wrong medication, air bubbles, and drug flow occlusion. Complications with wrong medication are causing thousands of deaths per year that in many cases can be prevented by this emerging technology. ISSYS is a leader in advanced micromachining technologies for medical devices, microfluidic and scientific analytical sensing applications. For more information, visit www.mems-issys.com.